Login Register Cart 0
Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Challenges in the Discovery of Novel Therapeutic Agents in Cancer

Author(s): Ganji Purnachandra Nagaraju and Mohammad Amjad Kamal*

Volume 20, Issue 12, 2019

Page: [931 - 932] Pages: 2

DOI: 10.2174/138920022012200102095006

Abstract

One of the major challenges currently facing cancer therapy is the development of drug resistance either intrinsically or as a result of treatment. Treatment evasion is mediated by an intricate web of signalling cascades and adaptations caused by selective therapeutic pressure, leading to metastatic spread and patient death. Hence, discovering and designing novel therapeutic compounds and regimens based on specific alterations in the cancer microenvironment and capable of overcoming resistance to traditional therapies is necessary to improve cancer survival outcomes. These new therapeutic modalities should exhibit improved solubility, penetration capacity and bioavailability in the tumor microenvironment as well as enhanced target specificity compared to old generation compounds. The success of this endeavour will contribute to the advent of precision medicine leading to personalized therapeutic approaches for patients.

Keywords: Cancer, drug resistance, therapy, genetic manipulations, stem cells, immune system, drug analogues.

« Previous Next »
[1]
Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin., 2019, 69(1), 7-34.
[http://dx.doi.org/10.3322/caac.21551] [PMID: 30620402]
[2]
Wu, Q.; Yang, Z.; Nie, Y.; Shi, Y.; Fan, D. Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches. Cancer Lett., 2014, 347(2), 159-166.
[http://dx.doi.org/10.1016/j.canlet.2014.03.013] [PMID: 24657660]
[3]
Kim, B.M.; Hong, Y.; Lee, S.; Liu, P.; Lim, J.H.; Lee, Y.H.; Lee, T.H.; Chang, K.T.; Hong, Y. Therapeutic implications for overcoming radiation resistance in cancer therapy. Int. J. Mol. Sci., 2015, 16(11), 26880-26913.
[http://dx.doi.org/10.3390/ijms161125991] [PMID: 26569225]
[4]
Chikara, S.; Nagaprashantha, L.D.; Singhal, J.; Horne, D.; Awasthi, S.; Singhal, S.S. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. Cancer Lett., 2018, 413, 122-134.
[http://dx.doi.org/10.1016/j.canlet.2017.11.002] [PMID: 29113871]
[5]
Belalcazar, A.; Nagaraju, G.P. Current knowledge on drug resistance and therapeutic approaches to eliminate pancreatic cancer stem cells. In: Theranostic Approach for Pancreatic Cancer; Purnachandra, G.; Ahmad, N.S., Eds.; Elsevier: Amsterdam, 2019; pp. 69-80.
[6]
Gopinath, S.C. Approaches in theranostics and pharmacological sciences. INNOSC Therano. Pharmacol. Sci., 2019, 2(1), 1-2.
[7]
Rajitha, B.; Malla, R.R.; Vadde, R.; Kasa, P.; Prasad, G.L.V.; Farran, B.; Kumari, S.; Pavitra, E.; Kamal, M.A.; Raju, G.S.R. Horizons of nanotechnology applications in female specific cancers, Seminars in cancer biology; Elsevier: Amsterdam, 2019.
[8]
Farran, B.; Montenegro, R.C.; Kasa, P.; Pavitra, E.; Huh, Y.S.; Han, Y-K.; Kamal, M.A.; Nagaraju, G.P.; Rama Raju, G.S. Folate-conjugated nanovehicles: Strategies for cancer therapy. Mater. Sci. Eng. C, 2020, 107, 110341
[http://dx.doi.org/10.1016/j.msec.2019.110341] [PMID: 31761235]

Rights & Permissions Print Cite
Article Metrics
6
1
1
© 2024 Bentham Science Publishers | Privacy Policy